ADDEX THERAPEUTICS SA NAM.-AKTIE
ADDEX THERAPEUTICS SA NAM.-AKTIE/ CH0029850754 /
A0MSH6
|
2024-05-27 5:17:50 PM
|
Chg.
+0.012
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
0.069EUR
|
+21.33%
|
-
Turnover: - |
-Bid Size: - |
-Ask Size: - |
13.08 mill.EUR |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-0.14 CHF |
-69.57% |
| EPS Diluted: |
- CHF |
-69.57% |
| Revenues per Share: |
0.01 CHF |
-23.86% |
| Book Value per Share: |
0.01 CHF |
-84.90% |
| Cash Flow per Share: |
-0.04 CHF |
-68.52% |
| Dividend per Share: |
- CHF |
- |
| Total |
in mill. |
|
| Revenues: |
1.65 CHF |
17.65% |
| Net Income: |
-10.56 CHF |
-49.25% |
| Operating Cash Flow: |
-7.99 CHF |
- |
| Cash and Cash Equivalents: |
3.87 CHF |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
7.88 |
4.98 |
| P/BV ratio: |
11.33 |
7.16 |
| P/CF Ratio: |
-1.62 |
-1.03 |
| PEG: |
0.01 |
- |
| Earnings Yield: |
-192.31% |
-304.35% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
13.08 mill. EUR |
8.83 mill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
- EUR |
- EUR |
| Shares Outstanding: |
178.23 mill. |
|
Profitability
| Gross Profit Margin: |
- |
| EBIT Margin: |
-624.22% |
| Net Profit Margin: |
-640.91% |
| Return on Equity: |
-921.57% |
| Return on Assets: |
-227.41% |
Financial Strength
| Liquidity I / Cash Ratio: |
133.60% |
| Liquidity II / Quick Ratio: |
137.42% |
| Liquidity III / Current Ratio: |
146.37% |
| Debt / Equity Ratio: |
305.25% |
| Dynam. Debt / Equity Ratio: |
-43.75% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- CHF |
| Revenues / Employee: |
- CHF |
| Net Income / Employee: |
- CHF |
| Total Assets / Employee: |
- CHF |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
IFRS |
